Article archive / October 1, 2012
Originally published: . Volume 4, No. 2. Source pages: 4.
In a news release September 4, the Louisiana Attorney General’s office reported that the Circuit Court of Appeal had upheld the $257.7 million jury verdict that the state Attorney General, Buddy Caldwell, had brought against Janssen Pharmaceutical and Johnson & Johnson.
Caldwell sued Johnson & Johnson for misrepresentation in regard to the drug Risperdal’s link to diabetes. This misrepresentation of facts then made it possible for the drug company to obtain funds from Louisiana’s Medicaid program, according to the news release.
“The appeals court ruling serves as a powerful reminder that a drug company’s misleading safety claims will not be tolerated in Louisiana,” said Attorney General Caldwell in the announcement.
This article is part of a historical newspaper archive. Read the original issue for its original layout, photographs and graphics.